Target intelligence / Profile preview

16S ribosomal RNA A-site of the 30S subunit of the bacterial ribosome (16S rRNA A-site)

Target
16S rRNA A-site
Molecular classification
Ribosomal RNA, Structural RNA, Macromolecular complex, Other
01

Overview

The 16S ribosomal RNA A-site, located within the 30S small subunit of the bacterial ribosome, is a conserved RNA domain responsible for decoding the mRNA codon during protein synthesis. The A-site is formed primarily by nucleotides G530, A1492, and A1493 of 16S rRNA, which undergo a dynamic induced-fit rearrangement to monitor and discriminate correct codon-anticodon pairing against non-cognate tRNA, ensuring translational fidelity[6][1][3]. The A-site is a critical binding pocket for several classes of antibiotics—most notably aminoglycosides—which perturb its structure or dynamics to inhibit translation and kill bacteria. Its essentiality and high sequence conservation make it both a robust phylogenetic marker and a validated antibacterial drug target. The A-site also interacts with ribosomal proteins and is involved in the initiation and elongation phases of translation[2][4][8].

Other names
16S rRNA decoding site30S ribosomal A-sitemRNA decoding siteAminoglycoside binding site
02

Mechanism of action

Drugs bind to the 16S rRNA A-site, causing local conformational changes in nucleotides (particularly A1492, A1493, G530), which disrupt accurate mRNA decoding and promote the incorporation of incorrect aminoacyl-tRNA, leading to errors in protein synthesis or premature termination. Inhibition of bacterial translation and cell viability.

03

Biological functions

mRNA decoding during translationStabilization of codon–anticodon pairingMaintenance of translational fidelityScaffold for ribosomal protein assemblyInitiation of protein synthesis
04

Disease associations

Infection
05

Safety considerations

Off-target effects: Human mitochondrial ribosomes share similarities and may be inadvertently affected by some aminoglycosides, causing toxicity.Ototoxicity and nephrotoxicity are major concerns with A-site-targeting aminoglycosides.Rapid development of bacterial resistance via mutations or methylation of rRNA.
06

Interacting drugs

Streptomycin

7 more in the full profile.

07

Biomarkers

Mutations in 16S rRNA (A1408G, C1409T, G1491A, etc.) associated with antibiotic resistance and predictive of therapeutic efficacy or failure

Beyond the preview

Go deeper on 16S ribosomal RNA A-site of the 30S subunit of the bacterial ribosome (16S rRNA A-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 16S ribosomal RNA A-site of the 30S subunit of the bacterial ribosome (16S rRNA A-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call